1. Home
  2. YMT vs SER Comparison

YMT vs SER Comparison

Compare YMT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMT

Yimutian Inc. American Depositary Shares

HOLD

Current Price

$0.54

Market Cap

19.4M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$1.81

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
SER
Founded
2011
2017
Country
China
United States
Employees
N/A
13
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
19.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YMT
SER
Price
$0.54
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
332.5K
76.3K
Earning Date
06-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$1.22
52 Week High
$2.85
$7.92

Technical Indicators

Market Signals
Indicator
YMT
SER
Relative Strength Index (RSI) 43.98 47.00
Support Level $0.40 $1.75
Resistance Level $0.72 $1.96
Average True Range (ATR) 0.12 0.19
MACD -0.03 -0.01
Stochastic Oscillator 24.01 21.28

Price Performance

Historical Comparison
YMT
SER

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: